Charles River Teams Up with Elly’s Team to Accelerate Gene Therapy for Ultra-Rare NEDAMSS Disorder Charles River Laboratories International, Inc. (NYSE: CRL), a global leader in early-stage drug development and manufacturing services, has announced a collaborative agreement with Elly’s Team,…
Bristol Myers Squibb’s Sotyktu Makes Global Regulatory Progress for Psoriatic Arthritis as FDA Accepts sNDA for Review In a major development for immunology-focused therapeutics, Bristol Myers Squibb (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) has…
Genentech Receives FDA Complete Response Letter for Columvi Combination Therapy in Second-Line Diffuse Large B-Cell Lymphoma; Reaffirms Commitment to Advancing Columvi Across the Treatment Landscape Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the…
Fresenius Kabi Honored with 2025 Premier Supplier Legacy Award for Continued Excellence in Healthcare Delivery Fresenius Kabi, a leading global healthcare company specializing in lifesaving medicines and technologies, has once again been recognized for its longstanding commitment to excellence in…
BioNTech’s Chief Strategy Officer Ryan Richardson to Step Down After Pivotal Seven-Year Tenure BioNTech SE (Nasdaq: BNTX), the German-based global biotechnology company known for its groundbreaking work in mRNA technology and immunotherapies, has announced that Ryan Richardson, its Chief Strategy…
Thermo Fisher and Sanofi Expand Strategic Partnership with U.S. Sterile Manufacturing Deal Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in scientific services, has announced a significant expansion of its strategic collaboration with French biopharmaceutical giant Sanofi. This move…
Tempus Secures FDA 510(k) Clearance for AI-Driven ECG-Low EF Software, Expanding Capabilities in Cardiovascular Risk Detection Tempus AI, Inc. (NASDAQ: TEM), a trailblazer in applying artificial intelligence to drive precision medicine forward, has reached a significant milestone in the cardiology…
Satellos Bioscience Names Renowned Neuromuscular Expert Dr. Wildon Farwell as Chief Medical Officer to Advance Duchenne Therapy Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF), a biotechnology company pioneering small molecule therapies to treat muscle diseases, has appointed Dr. Wildon Farwell,…
C2N Diagnostics Unveils Two Groundbreaking Blood Tests to Advance Alzheimer’s Research and Precision Diagnostics C2N Diagnostics, LLC, a trailblazer in brain health diagnostics, has announced the launch of two innovative plasma-based assays designed for Research Use Only, expanding its suite…
ZYUS Life Sciences Appoints Dr. Julie Stakiw as Chief Medical Officer to Advance Phase 2 Oncology Pain Program and Strengthen Clinical Development Leadership In a pivotal step toward accelerating its clinical development strategy and reinforcing its commitment to addressing the…
HistoSonics Expands Access to Groundbreaking Non-Invasive Liver Tumor Treatment as Highmark Covers Histotripsy for 7 Million Members In a pivotal development for patients battling liver tumors, HistoSonics, the medical technology company behind the innovative Edison® Histotripsy System, announced that Highmark…
ViiV Healthcare Broadens Voluntary Licensing Deal with MPP to Include Long-Acting Injectable HIV Treatment in Global Access Push GSK plc (LSE/NYSE: GSK) announced that its majority-owned subsidiary, ViiV Healthcare—a global leader in HIV treatment and prevention, with Pfizer and Shionogi…